Skip to main content
Onesource Specialty Pharma Limited logo

Onesource Specialty Pharma Limited — Investor Relations & Filings

Ticker · ONESOURCE ISIN · INE013P01021 LEI · 335800TP5C932B9IQT98 BSE.NS Manufacturing
Open in API
Filings indexed 156 across all filing types
Latest filing 2025-02-27 Regulatory Filings
Country IN India
Listing BSE.NS ONESOURCE

About Onesource Specialty Pharma Limited

https://www.onesourcecdmo.com/

Onesource Specialty Pharma Limited is a specialized Contract Development and Manufacturing Organization (CDMO) providing integrated solutions for complex pharmaceutical products. The company focuses on the development and large-scale manufacturing of specialty injectables, softgel capsules, and complex formulations. Its service portfolio encompasses the entire product lifecycle, including formulation development, clinical trial supply, and commercial-stage production. Onesource operates advanced manufacturing facilities designed to meet global regulatory standards, catering to diverse therapeutic areas. By leveraging technical expertise in sterile products and differentiated dosage forms, the organization supports global pharmaceutical partners in bringing high-entry-barrier medicines to market. The platform is built on a foundation of quality compliance and operational excellence to ensure the delivery of critical healthcare solutions.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of an analyst/institutional investor meeting pursuant to SEBI regulations. It explicitly states the meeting date and that no unpublished price sensitive information will be shared. The document does not contain any financial data, detailed report, or results. It is an announcement of an event related to investor relations, not a financial report or detailed presentation. The length is only 1717 characters, which is quite short and fits the profile of a regulatory announcement rather than a full report or presentation. Therefore, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous regulatory announcements that do not fit other categories.
2025-02-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchanges about the schedule of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements but does not contain any financial data, detailed financial reports, or results. It explicitly states that the discussion will be based on publicly available information and no unpublished price sensitive information will be shared. The document is an announcement of a meeting schedule rather than a report or transcript of the meeting. Given the short length (1746 characters) and the nature of the content, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-27 English
Credit Rating
Audit Report / Information Classification · 95% confidence The document is a detailed press release from CARE Ratings Limited dated February 20, 2025, providing a credit rating update for OneSource Specialty Pharma Limited. It discusses the credit rating upgrades, reaffirmations, and withdrawals for various bank facilities and non-convertible debentures. The document includes detailed financial and operational information such as revenue growth, profit margins, equity infusion, debt repayment, and future outlook. It also covers the rationale behind the ratings, key strengths and weaknesses of the company, and rating sensitivities. The content is focused on credit rating information and financial analysis rather than a full annual or quarterly report, earnings release, or regulatory filing. Given the nature of the document as a standalone audit/credit rating report issued by a rating agency, it fits best under the category of Audit Report / Information (AR). The document is not an announcement of a report but the report itself, and it contains substantive financial and operational data relevant to credit assessment.
2025-02-21 English
Cessation
Board/Management Information Classification · 100% confidence The document is a formal notification addressed to stock exchanges about a change in senior management personnel, specifically the termination of Mr. Jason T Spacek as Chief Business Officer. It references compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events including changes in senior management. The content includes details of the cessation date and reason for change but does not contain financial data, earnings, or report content. It is an announcement of management change rather than a full management report or financial filing. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 3392 characters, which is consistent with a brief announcement rather than a full report.
2025-02-21 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a formal notification addressed to stock exchanges about the schedule of an analyst/institutional investor meeting. It references compliance with SEBI Listing Obligations and Disclosure Requirements Regulation 2015, specifically Regulation 30, which pertains to disclosure of material events. The content states the meeting will discuss publicly available information and no unpublished price sensitive information will be shared. The document is short (1747 characters) and serves as an announcement of a scheduled event rather than a report or detailed financial disclosure. It does not contain financial statements, audit information, voting results, or executive changes. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-02-20 English
Appointment
Board/Management Information Classification · 100% confidence The document is an official communication addressed to stock exchanges regarding a change in senior management personnel, specifically the appointment of a new Chief Quality Officer. It references compliance with SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosures related to corporate governance and management changes. The content includes details about the appointment date, the profile of the appointee, and the regulatory basis for disclosure. There are no financial statements, earnings data, or audit information present. The document is clearly an announcement of a management change rather than a financial report or other filing type. Therefore, the appropriate classification is 'Board/Management Information' (MANG). The document length is 4422 characters, which is consistent with a detailed announcement rather than a brief notice or a full report.
2025-02-14 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.